Skip to main content
Premium Trial:

Request an Annual Quote

European Investment Group Permira to Acquire for $1.6B

Premium and Permira this week announced a merger agreement under which Permira Advisors LLP, a company held by Permira and other investors, will acquire Provo, Utah-based for $32 per share in cash, a transaction valued at $1.6 billion.

The companies noted in a statement that the deal is subject to the approval of shareholders and customary closing conditions and that they expect it to close in early 2013.

Headquartered in London, Permira has offices around the world and advises funds with a total committed capital of $26 billion. CEO Tim Sullivan said that the agreement with Permira will allow it to "keep investing in our technology and product experience" and to "make family history easy and accessible for more and more families around the world."

In addition to offering its 2-million-plus subscribers access to digitized and indexed records, in May entered the genetic genealogy market, launching AncestryDNA, an autosomal DNA testing service (BAN 5/29/2012). AncestryDNA relies on Illumina HumanOmniExpress BeadChips to generate data that is used to inform clients about their relationships to other subscribers and deep ancestry. The company recently said it plans to make the raw data from the service downloadable for interested users (see related story, this issue).

Should the deal close as expected,'s focus will "continue to be on investing in content, technology, and its user experience, expanding its product offerings in areas like DNA, and building the brand and the family history category, all on a global basis," the companies said. said it will file additional details regarding the transaction shortly with the US Securities and Exchange Commission, and in proxy materials to be provided to the company's stockholders in connection with a special meeting to vote on the merger.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.